News

26.10.2021

HTx – Next Generation Health Technology Assessment

How to decide on the best standard of care for a person with MS? What if patients could contribute to…

ECTRIMS 2021 – Day 3 Keep us moving – from Patient Perspectives to Rehabilitation

18.10.2021

The themes of ECTRIMS Day 3 gave the audience a perspective and a view into the future. Discussed topics included…

ECTRIMS 2021 – Day 2 The Digital Experience Goes into the Next Round!

15.10.2021

The themes of ECTRIMS Day 2 were spinning around Disease-Modifying Treatments (DMTs) addressing the question if and when to stop,…

14.10.2021

ECTRIMS 2021 Day 1 – The Digital Experience in Multiple Sclerosis has started

This years’ ECTRIMS Congress – the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis –…

Nose-to-Brain-Patch Final Outcomes

29.09.2021

Effective drugs for the treatment of diseases of the central nervous system such as multiple sclerosis do exist. However, the…

Updated global COVID-19 advice for people with MS

06.06.2021

Global COVID-19 advice for people with MS | Last updated: 23 March 2022 What’s on this page? Global COVID-19 advice…

31.03.2021

#EMSPVirtual2020 Summary

Mid-November was not the usual time for an EMSP conference. In the last weeks of 2020, the European MS community…

Cornelia Păuna – The dreamers are the saviours of the world

31.03.2021

Representing young people with MS at the highest European level EMSP continues building on the current Young People’s Network to…

Childhood MS on Rare Diseases Day 2021

26.02.2021

Do you remember when you were 9? Or 15? We might not recal­l all our youth but there are parts…

1 6 7 8 9 10 29